The revolution of semisolid pharmaceutical formulations
The evolution of semisolid pharmaceutical forms has marked a decisive advancement in the fields of pharmacology and dermopharmacy. Creams, gels, ointments, and emulsions have become established as reference therapeutic systems due to their versatility, ease of application, and high patient acceptance.
In recent years, applied research has driven a profound transformation in the formulations, integrating advances in material technology, biological knowledge, and digital tools. The innovation goes beyond sensory or aesthetic aspects, responding increasingly stringent scientific criteria aimed at improving the efficacy, safety, and stability of treatments. In this regard, European Directive 2001/83/CE sets the regulatory framework for the authorization, marketing, and supervision of medicines, ensuring that all semisolid pharmaceutical formulations meet the necessary standards of safety, efficacy, and quality to protect public health.
New approaches in the formulation of semisolid pharmaceutical forms
Modern design of semisolid pharmaceutical forms is based on advanced knowledge of skin physiology and the interactions between active ingredients and excipients. The skin is now considered a dynamic organ whose permeability can be modulated through appropriate formulation technologies.
This approach has enabled the development of structured matrices that favor controlled drug release and enhance its penetration into specific skin layers, optimizing local bioavailability and reducing undesirable systemic effects.
Micro and nanometric systems
One of the most significant advancements is the incorporation of structured systems at the micro and nanometric scale, such as liposomes, polymeric nanoparticles, and self-emulsifying systems. These technologies improve the stability of sensitive active ingredients, reduce degradation, and allow the use of lower concentrations without compromising clinical efficacy.
Innovation applied to dermopharmacy
In the field of dermopharmacy, semisolid dosage formulations have evolved to meet the growing demand for personalized treatments. The increase in chronic skin conditions, population aging, and greater awareness of skin health have driven the development of more specific formulations.
Innovation is focused on adapting texture, spreadability, and absorption rate to different skin types and clinical conditions, enhancing user experience and treatment adherence.
Functional excipients and smart polymers
The development of functional excipients has been key in this evolution. Polymers capable of responding to changes in pH, temperature, or hydration enable the creation of products that modify their behavior according to the skin environment, enhancing therapeutic efficacy and reducing adverse reactions.
Stability and safety as pillars of development
Physical-chemical stability remains one of the main challenges in the development of semisolid pharmaceutical forms. Phenomena such as phase separation, oxidation, or loss of active ingredient activity can compromise the final product’s quality.
Advances in analytical techniques and predictive models allow the identification of these risks from the early stages of development, optimizing the formulation and reducing costs associated with reformulations.
Furthermore, there is a clear trend towards the use of alternative preservatives and safer antimicrobial protection systems, supported by airless packaging and excipients with intrinsic antimicrobial activity.
Technology, digitalization, and quality control
The incorporation of digital tools has transformed the development of semisolid forms. Computational simulation and in silico models allow the evaluation of drug release, stability, and interaction with the skin before conducting physical trials.
The automation of processes and advanced quality control ensure greater reproducibility between batches, a critical aspect in pharmacology to meet regulatory requirements and ensure therapeutic equivalence.
Sustainability and market demands
Innovation in semisolid pharmaceutical forms is also shaped by sustainability criteria. The selection of biodegradable raw materials, more efficient processes, and reduction of environmental impact are part of current development strategies.
The balance between sustainability, therapeutic efficacy, and economic feasibility has become a key differentiating factor for companies in the sector, enabling them to offer competitive products without compromising quality or patient safety.
Towards personalization: The future of semisolid pharmaceutical forms
The future of semisolid pharmaceutical forms is geared toward greater personalization and therapeutic precision. The convergence of biotechnology, material science, and data analysis will enable the development of systems increasingly tailored to individual needs, consolidating their key role in pharmacology and dermopharmacy.
